Log in

The risk of hospitalisation from RSV is not increased by co-infection in children under 24-months-of-age

  • BRIEF REPORT
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The recent pandemic prompted renewed interest in paediatric respiratory infections, including whether co-infections – particularly with RSV – have an adverse prognostic impact. We evaluated the charts of all children presenting with respiratory symptoms to our unit between October 2022 and April 2023, each of whom was subjected to a multiplex PCR assay to detect eight viral targets and one bacterial target and examine the relationships between mono- and co-infections and hospitalization outcomes. We observed that younger age and RSV infection were both associated with the need for hospitalisation and the duration of hospitalisation after adjusting for confounders. Co-infection was, however, not associated with these outcomes.

  Conclusion: This real-world data add to a growing consensus that RSV increases the risk of hospitalisation, while other co-infections, except for co-infection with SARS-CoV-2, do not. Given the timeframe over which our study was conducted, only a few children had SARS-CoV-2 co-infection, so we could not confirm any significant effect from this interaction.

What is Known:

• RSV increases the risk of hospitalisation and the need tor ventilatory support, especially in very young children.

What is New:

• Younger age and RSV infection were both associated with the need for hospitalisation and the duration of hospitalisation after adjusting for confounders.

• Co-infection was, however, not associated with these outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

Data are available from the corresponding author upon a reasonable request.

References

  1. Hall CB, Simőes EA, Anderson LJ (2013) Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol 372:39–57

    PubMed  Google Scholar 

  2. Rabbone I, Monzani A, Scaramuzza AE, Cavalli C (2022) See-sawing COVID-19 and RSV bronchiolitis in children under 2 years of age in Northern Italy. Acta Paediatr 111(11):2174–2175

    Article  CAS  PubMed  Google Scholar 

  3. Messacar K, Baker RE, Park SW, Nguyen-Tran H, Cataldi JR, Grenfell B (2022) Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet 400(10364):1663–1665

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. González-Martinez F, de la Mata NS, Mejias A et al (2022) Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes. J Allergy Clin Immunol Glob 1(3):91–98

    Article  PubMed  PubMed Central  Google Scholar 

  5. Li Y, Pillai P, Miyake F et al (2020) The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): a systematic review and meta-analysis. J Glob Health 10:010426

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rodriguez-Fernandez R, González-Martínez F, Perez-Moreno J et al (2023) Clinical relevance of RSV and SARS-CoV-2 coinfections in infants and young children. Pediatr Infect Dis J. https://doi.org/10.1097/INF.0000000000004080

    Article  PubMed  Google Scholar 

Download references

Funding

Laboratory assays were performed as per usual care of patients attending the ED. There was no specific funding for this study.

Author information

Authors and Affiliations

Authors

Contributions

ACFF, AES and CC Conceptualized the study; AES, MG, FR, CV, GF, MS and BAD conducted the study; EG made statistical analysis; LC and ST performed laboratory assays; ACFF, MG, FR, VC and CV wrote the draft of the manuscript; all authors critically discussed data and the final draft of the manuscript; AES and CC edited the last version of the paper. All authors approved the final draft of the manuscript.

Corresponding author

Correspondence to Andrea Enzo Scaramuzza.

Ethics declarations

Ethics statement

All data were analysed after anonymisation. The local Ethics Committee approved the protocol, and the study was conducted according to the Declaration of Helsinki.

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by Peter de Winter

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 80 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferrari, A.C.F., Giani, E., Scaramuzza, A.E. et al. The risk of hospitalisation from RSV is not increased by co-infection in children under 24-months-of-age. Eur J Pediatr 183, 1943–1945 (2024). https://doi.org/10.1007/s00431-024-05440-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-024-05440-7

Navigation